Details of the Drug Reposition

General Information of This Drug (ID: DM6CJ12)

Drug Name
BMX-010   DM6CJ12
Synonyms
Bmx-010; UNII-BN93L2NT5I; BN93L2NT5I; Manganese(III)meso-tetrakis(N-ethylpyridinium-2-yl) porphyrin chloride; Manganese(4+), chloro((2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl-kappaN21,kappaN22,kappaN23,kappaN24)tetrakis(1-ethylpyridiniumato))(2-))-, tetrachloride, (sp-5-12)-; 219818-60-7
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Atopic dermatitis DISTCP41 EA80 Phase 2 [1]
Plaque psoriasis DISQX1LF EA90.0 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)